首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

【24h】

Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

机译：抗gp210和抗着丝粒抗体可预测PBC患者对UDCA和苯扎贝特的生化反应不完全

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology research: the official journal of the Japan Society of Hepatology》 |2015年第8期|共2页
作者
Honda Akira; Ikegami Tadashi; Matsuzaki Yasushi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate [J] . Honda Akira, Ikegami Tadashi, Matsuzaki Yasushi Hepatology research: the official journal of the Japan Society of Hepatology . 2015,第8期

机译：抗gp210和抗着丝粒抗体可预测PBC患者对UDCA和苯扎贝特的生化反应不完全
2. Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA [J] . Tanaka Atsushi, Hirohara Junko, Nakanuma Yasuni, Journal of gastroenterology . 2015,第6期

机译：对苯扎贝特的生化反应可改善无症状的原发性胆汁性肝硬化的难治性UDCA患者的长期预后
3. Relationships between biochemical response to UDCA and progression of liver stiffness as determined by Fibroscan in patients with PBC [J] . Corpechot Christophe, Gaouar Farid, Lemoinne Sara, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：PBC患者纤维植物测定的UDCA对UDCA的生化反应与肝硬化进展的关系
4. Learning decision rules from incomplete biochemical risk factor indicators to predict cardiovascular risk level for adult patients [C] . Yaya Heryadi, Eka Miranda, Harco Leslie Hendric Spits Warnars 2017 IEEE International Conference on Cybernetics and Computational Intelligence . 2017

机译：从不完整的生化危险因素指标中学习决策规则，以预测成年患者的心血管风险水平
5. ASSOCIATION OF DISEASE WITH THE ALLOANTIGENS AND BIOCHEMICAL POLYMORPHISMS IN THE BLOOD OF CATTLE: ANTIBODY RESPONSE TO BLV GP-69 AS A MODEL [D] . MAURER, JAMES KYLE. 1981

机译：牛血液中疾病与同种异体抗原和生化多态性的关联：抗体对BLV GP-69的反应
6. Nomogram for the Prediction of Biochemical Incomplete Response in Papillary Thyroid Cancer Patients [O] . Seung Taek Lim, Ye Won Jeon, Hongki Gwak, 2021

机译：用于预测乳头状甲状腺癌患者生物化学不完全反应的罗维图
7. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA [O] . Jörn M. Schattenberg, Albert Pares, Kris V. Kowdley, 2021

机译：患有原发性胆管炎患者的Alafibranor的随机安慰剂对照试验和对UDCA的不完全反应
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Biochemically Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer [R] . Tagawa, S. T. 2010

机译：177Lu放射性标记的抗psma生化单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号